SARNICO, Ilenia Tiziana
 Distribuzione geografica
Continente #
EU - Europa 1.463
NA - Nord America 1.335
AS - Asia 382
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
SA - Sud America 4
AF - Africa 2
Totale 3.198
Nazione #
US - Stati Uniti d'America 1.328
PL - Polonia 735
CN - Cina 251
DE - Germania 212
UA - Ucraina 205
GB - Regno Unito 74
IT - Italia 70
FI - Finlandia 54
IN - India 54
FR - Francia 37
HK - Hong Kong 31
IE - Irlanda 31
RU - Federazione Russa 28
SG - Singapore 22
VN - Vietnam 18
BE - Belgio 12
EU - Europa 8
CA - Canada 6
AU - Australia 3
CL - Cile 3
MU - Mauritius 2
NL - Olanda 2
SE - Svezia 2
TR - Turchia 2
BR - Brasile 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 3.198
Città #
Warsaw 735
Woodbridge 159
Jacksonville 151
Chandler 134
Fairfield 125
Houston 109
Ashburn 96
Ann Arbor 91
Princeton 61
Dearborn 57
Nanjing 55
Seattle 55
Cambridge 49
Brescia 45
Wilmington 44
Beijing 40
Dublin 31
Hong Kong 30
New York 28
Pune 26
Helsinki 25
Lancaster 25
Nanchang 22
Dong Ket 18
Changsha 14
Des Moines 14
Jinan 14
Hebei 13
Brussels 12
Shenyang 12
Tianjin 12
Shanghai 11
Singapore 11
Ningbo 9
London 8
Guangzhou 7
Jiaxing 7
San Diego 6
Verona 6
Kunming 5
Los Angeles 5
Nürnberg 5
Zhengzhou 5
Lanzhou 4
Orange 4
Ottawa 4
Hangzhou 3
Milan 3
San Francisco 3
Sondrio 3
Taizhou 3
Berlin 2
Kilburn 2
Livorno 2
Phoenix 2
Toronto 2
Auckland 1
Canberra 1
Central 1
Changchun 1
Charlotte 1
Chicago 1
Chions 1
Chiswick 1
Dalmine 1
Florence 1
Fuzhou 1
Haikou 1
Hanover 1
Harbin 1
Hefei 1
Hounslow 1
Indiana 1
Kemerovo 1
Kocaeli 1
Lhasa 1
Lübeck 1
Madrid 1
Mexico City 1
Mykolayiv 1
Napoli 1
Norwalk 1
Novokuznetsk 1
Oklahoma City 1
Paris 1
Perth 1
Quzhou 1
San Mateo 1
Santa Clara 1
Taiyuan 1
Walnut 1
Zhangzhou 1
Totale 2.460
Nome #
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 268
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 232
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 222
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 211
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 171
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 154
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 147
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 132
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 117
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 106
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 101
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 99
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 96
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 96
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 95
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 93
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 84
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 81
Targeting epigenetic regulation of NF-KappaB and histones in the therapy of post-ischemic brain injury 77
ACETYLATION OF NF-KAPPAB p65 IN THE EPIGENETIC REGULATION OF TRANSCRIPTION: A NEUROPROTECTIVE TARGET IN BRAIN ISCHEMIA 73
Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-{kappa}B/c-Rel-Dependent Transcription. 72
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 71
NF-kappaB dimer heterogeneity: a molecular determinant of neuron vulnerability in post ischemic brain damage 67
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 64
CHF5074 reduces brain β-amyloid burden in a mouse model of Alzheimer’s disease by modulating APP and PS1 interaction 62
TRAIL PATHWAY IN BETA AMYLOID NEUROTOXICITY 58
TARGETING NF-KAPPAB AND EPIGENETIC CHROMATIN REMODELLING IN THE THERAPY OF POST-ISCHEMIC BRAIN INJURY 58
Activation of NF-κB c-Rel complexes reduces neuron susceptibility to amyloid β peptide 58
CHF5074 reduces brain β-amyloid burden and hyperphosphorylated tau in a mouse model of Alzheimer’s disease 57
NF-κB p50/RELA AND c-REL-CONTAINING DIMERS: OPPOSITE REGULATORS OF NEURON VULNERABILITY TO ISCHEMIA 54
TARGETING NF-KAPPAB AND EPIGENETIC CHROMATIN REMODELLING IN THE THERAPY OF POST-ISCHEMIC BRAIN INJURY 54
Totale 3.330
Categoria #
all - tutte 11.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201955 0 0 0 0 0 0 0 0 0 0 0 55
2019/2020943 116 43 41 75 54 118 76 111 51 161 46 51
2020/2021454 14 56 14 59 22 47 31 53 73 27 35 23
2021/2022251 11 64 0 3 4 4 15 12 17 35 23 63
2022/2023291 31 13 18 28 33 78 0 26 41 0 10 13
2023/2024247 21 4 36 8 12 76 8 19 32 7 5 19
Totale 3.330